Catalyst Pharmaceuticals Inc (CPRX)
21.48
+0.36
(+1.70%)
USD |
NASDAQ |
Nov 22, 16:00
21.65
+0.17
(+0.79%)
After-Hours: 05:06
Catalyst Pharmaceuticals Profit Margin (Quarterly): 34.10% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 34.10% |
| June 30, 2024 | 33.24% |
| March 31, 2024 | 23.63% |
| December 31, 2023 | 31.51% |
| September 30, 2023 | -29.96% |
| June 30, 2023 | 37.92% |
| March 31, 2023 | 34.64% |
| December 31, 2022 | 41.92% |
| September 30, 2022 | 39.74% |
| June 30, 2022 | 40.70% |
| March 31, 2022 | 30.73% |
| December 31, 2021 | 24.30% |
| September 30, 2021 | 28.73% |
| June 30, 2021 | 33.50% |
| March 31, 2021 | 25.37% |
| December 31, 2020 | 36.88% |
| September 30, 2020 | |
| June 30, 2020 | 33.04% |
| March 31, 2020 | 35.78% |
| December 31, 2019 | 26.32% |
| September 30, 2019 | 44.11% |
| June 30, 2019 | 38.01% |
| March 31, 2019 | -5.18% |
| December 31, 2018 | -2.90K% |
| September 30, 2018 |
| Date | Value |
|---|---|
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-29.96%
Minimum
Sep 2023
41.92%
Maximum
Dec 2022
29.58%
Average
33.24%
Median
Jun 2024
Profit Margin (Quarterly) Benchmarks
| Corcept Therapeutics Inc | 25.86% |
| Vertex Pharmaceuticals Inc | 37.71% |
| Sarepta Therapeutics Inc | 7.19% |
| ADMA Biologics Inc | 29.96% |
| BioVie Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 27.81% |
| Return on Assets | 23.73% |
| Return on Invested Capital | 27.81% |
| Gross Profit Margin (Quarterly) | 85.02% |
| Operating Margin (Quarterly) | 39.56% |
| Return on Net Operating Assets | 53.05% |